Anaeropharma Science, Inc.
13Patents
12Active
13Granted
49Portfolio score
Filing activity: Feb 23, 2004 → Jan 18, 2016 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7740835B2 | Anaerobic bacterium as a drug for cancer gene therapy | Chemistry; Metallurgy | 16 | Expired |
| US8734779B2 | 5-fluorouracil-resistant bacteria and method for production thereof | Chemistry; Metallurgy | 13 | Active |
| US8021653B2 | Shuttle vector for Bifidobacterium and Escherichia coli | Emerging Cross-Sectional Technologies | 6 | Active |
| US8535939B2 | Transfection vector | Human Necessities | 6 | Active |
| US8338162B2 | Obligately anaerobic mutant lactic acid bacterium and preparation method therefor, and expression vector functioning in obligately anaerobic lactic acid bacterium | Human Necessities | 4 | Active |
| US9730968B2 | Therapeutic agent for ischemic diseases | Chemistry; Metallurgy | 2 | Active |
| US8383398B2 | Expression vector | Human Necessities | 2 | Active |
| US9228191B2 | Transfection vector | Human Necessities | 1 | Active |
| US8911721B2 | Method of constructing gene transport support | Emerging Cross-Sectional Technologies | 0 | Active |
| US8470311B2 | Therapeutic agent for anaerobic diseases | Chemistry; Metallurgy | 0 | Active |
| US10443061B2 | Heterologous polypeptide expression cassette | Chemistry; Metallurgy | 0 | Active |
| US10563208B2 | Co-expression plasmid | Chemistry; Metallurgy | 0 | Active |
| US10993972B2 | Therapeutic agent for ischemic diseases | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.